Analysen von Marc Goodman
| 12.12.12 | Teva Pharmaceutical Industries neutral | UBS AG | |
| 10.12.12 | Bristol-Myers Squibb neutral | UBS AG | |
| 03.12.12 | Teva Pharmaceutical Industries neutral | UBS AG | |
| 09.10.12 | Eli Lilly neutral | UBS AG | |
| 01.10.12 | Eli Lilly neutral | UBS AG | |
| 28.08.12 | Eli Lilly neutral | UBS AG | |
| 03.08.12 | Bristol-Myers Squibb neutral | UBS AG | |
| 26.07.12 | Bristol-Myers Squibb neutral | UBS AG | |
|
Werbung
|
|||
| 20.07.12 | Bristol-Myers Squibb neutral | UBS AG | |
| 27.10.11 | Bristol-Myers Squibb neutral | UBS AG | |
| 27.06.11 | Bristol-Myers Squibb neutral | UBS AG | |
| 23.06.11 | Bristol-Myers Squibb neutral | UBS AG | |